Imperial College London at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Imperial College London brings 2 presentations to SITC 2026 in Phoenix. Its program centres on boosting immunotherapy and on why some patients respond poorly. One study combines collagen-targeting IL-12 with doxorubicin against osteosarcoma, and another links type 2 diabetes to weaker immunotherapy responses through a shift in the Th17 and Th1 helper T cell balance.
| Organization | SITC 2026 Attendance |
|---|---|
Imperial College London London, United Kingdom | |
A public research university with work spanning science, medicine and engineering. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Instantly find 20 buyers from Imperial College London
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction